TECTONIC THERAPEUTIC, INC. Operating Cash Flow
TECTONIC THERAPEUTIC, INC. (TECX) reported Operating Cash Flow of -$39.86 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- TECTONIC THERAPEUTIC, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$21.45M.
- TECTONIC THERAPEUTIC, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$18.41M.
- TECTONIC THERAPEUTIC, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$14.46M.
- TECTONIC THERAPEUTIC, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$17.82M.
- TECTONIC THERAPEUTIC, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$60.08M.
- TECTONIC THERAPEUTIC, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$59.08M.
- TECTONIC THERAPEUTIC, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$40.68M.
- TECTONIC THERAPEUTIC, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$97.21M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$21.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$39.86M 10-Q · filed 2026-08-06 | -$54.33M derived: sum of 3 quarters · filed 2026-08-06 | -$72.14M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$18.41M 10-Q · filed 2026-05-07 | -$32.87M derived: sum of 2 quarters · filed 2026-05-07 | -$50.69M derived: sum of 3 quarters · filed 2026-05-07 | -$65.41M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$14.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$32.28M derived: sum of 2 quarters · filed 2026-02-26 | -$46.99M derived: sum of 3 quarters · filed 2026-08-06 | -$60.08M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | -$17.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$32.53M derived: sum of 2 quarters · filed 2026-08-06 | -$45.62M 10-Q · filed 2025-11-06 | -$62.44M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$14.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$27.80M 10-Q · filed 2026-08-06 | -$44.62M derived: sum of 3 quarters · filed 2026-08-06 | -$64.23M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$13.08M 10-Q · filed 2026-05-07 | -$29.90M derived: sum of 2 quarters · filed 2026-05-07 | -$49.51M derived: sum of 3 quarters · filed 2026-05-07 | -$62.89M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | -$16.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$36.42M derived: sum of 2 quarters · filed 2026-02-26 | -$49.81M derived: sum of 3 quarters · filed 2026-02-26 | -$59.08M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | -$19.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$32.99M derived: sum of 2 quarters · filed 2025-11-06 | -$42.26M 10-Q · filed 2025-11-06 | -$53.92M derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | -$13.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$22.66M 10-Q · filed 2025-08-07 | -$34.31M derived: sum of 3 quarters · filed 2025-08-07 | -$42.79M derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | -$9.27M 10-Q · filed 2025-05-08 | -$7.57M 10-Q · filed 2024-05-09 | -$20.93M derived: sum of 2 quarters · filed 2025-05-08 | -$29.41M derived: sum of 3 quarters · filed 2025-05-08 | -$29.67M derived: sum of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | -$11.66M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$20.14M derived: sum of 2 quarters · filed 2025-03-20 | -$20.40M derived: sum of 3 quarters · filed 2025-03-20 | -$40.68M 10-K · filed 2025-03-20 | -$63.19M 10-K · filed 2024-03-14 | |||
| 2023-09-30 | -$8.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$8.74M derived: sum of 2 quarters · filed 2024-11-12 | -$29.02M 10-Q · filed 2024-11-12 | -$55.16M 10-Q · filed 2023-11-09 | -$52.70M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | -$259.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$20.54M 10-Q · filed 2024-08-14 | -$34.94M 10-Q · filed 2023-08-10 | -$44.22M derived: sum of 3 quarters · filed 2024-08-14 | -$60.63M derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | -$20.28M 10-Q · filed 2024-05-09 | -$43.96M derived: sum of 2 quarters · filed 2024-05-09 | -$60.37M derived: sum of 3 quarters · filed 2024-05-09 | -$89.48M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | -$23.67M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$40.09M derived: sum of 2 quarters · filed 2024-03-14 | -$69.19M derived: sum of 3 quarters · filed 2024-03-14 | -$97.21M 10-K · filed 2024-03-14 | ||||
| 2022-09-30 | -$16.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$45.52M derived: sum of 2 quarters · filed 2023-11-09 | -$73.53M 10-Q · filed 2023-11-09 | -$99.43M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | -$29.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$57.12M 10-Q · filed 2023-08-10 | -$83.02M derived: sum of 3 quarters · filed 2023-08-10 | -$107.84M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$28.01M 10-Q · filed 2023-05-11 | -$53.91M derived: sum of 2 quarters · filed 2023-05-11 | -$78.73M derived: sum of 3 quarters · filed 2023-05-11 | -$98.70M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$25.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$50.72M derived: sum of 2 quarters · filed 2023-03-23 | -$70.69M derived: sum of 3 quarters · filed 2023-03-23 | -$98.03M 10-K · filed 2023-03-23 | ||||
| 2021-09-30 | -$24.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$44.79M derived: sum of 2 quarters · filed 2022-11-08 | -$72.13M 10-Q · filed 2022-11-08 | -$102.62M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | -$19.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$47.30M 10-Q · filed 2022-08-09 | -$77.79M derived: sum of 3 quarters · filed 2022-08-09 | -$102.66M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | -$27.34M 10-Q · filed 2022-05-10 | -$57.83M derived: sum of 2 quarters · filed 2022-05-10 | -$82.69M derived: sum of 3 quarters · filed 2022-05-10 | -$103.71M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | -$30.49M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$55.35M derived: sum of 2 quarters · filed 2022-03-17 | -$76.37M derived: sum of 3 quarters · filed 2022-03-17 | -$98.80M 10-K · filed 2022-03-17 | ||||
| 2020-09-30 | -$24.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$45.88M derived: sum of 2 quarters · filed 2021-11-04 | -$68.31M 10-Q · filed 2021-11-04 | -$86.90M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | -$21.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$43.45M 10-Q · filed 2021-08-05 | -$62.03M derived: sum of 3 quarters · filed 2021-08-05 | -$75.42M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | -$22.43M 10-Q · filed 2021-05-13 | -$41.02M derived: sum of 2 quarters · filed 2021-05-13 | -$54.40M derived: sum of 3 quarters · filed 2021-05-13 | -$72.36M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | -$18.58M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$31.96M derived: sum of 2 quarters · filed 2021-03-18 | -$49.93M derived: sum of 3 quarters · filed 2021-03-18 | -$67.67M 10-K · filed 2021-03-18 | ||||
| 2019-09-30 | -$13.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$31.35M derived: sum of 2 quarters · filed 2020-11-05 | -$49.09M 10-Q · filed 2020-11-05 | -$60.52M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | -$17.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$35.70M 10-Q · filed 2020-08-06 | -$47.14M derived: sum of 3 quarters · filed 2020-08-06 | -$59.12M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | -$17.74M 10-Q · filed 2020-05-07 | -$29.17M derived: sum of 2 quarters · filed 2020-05-07 | -$41.16M derived: sum of 3 quarters · filed 2020-05-07 | -$49.41M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | -$11.43M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$23.42M derived: sum of 2 quarters · filed 2020-03-16 | -$31.67M derived: sum of 3 quarters · filed 2020-03-16 | -$37.65M 10-K · filed 2020-03-16 | ||||
| 2018-09-30 | -$11.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$20.23M derived: sum of 2 quarters · filed 2019-11-07 | -$26.21M 10-Q · filed 2019-11-07 | -$35.04M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | -$8.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$14.23M 10-Q · filed 2019-08-08 | -$23.05M derived: sum of 3 quarters · filed 2019-08-08 | -$26.15M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | -$5.98M 10-Q · filed 2019-05-13 | -$14.81M derived: sum of 2 quarters · filed 2019-05-13 | -$17.90M derived: sum of 3 quarters · filed 2019-05-13 | |||||
| 2017-12-31 | -$8.83M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | -$11.92M derived: sum of 2 quarters · filed 2019-03-25 | -$16.38M 10-K · filed 2019-03-25 | |||||
| 2017-09-30 | -$3.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$7.56M 10-Q · filed 2018-11-13 | ||||||
| 2017-06-30 | -$4.46M 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |